China

Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson’s Disease via the TLR4/PI3K/AKT/NF-κB Pathway Stimulated by α-Synuclein

A mouse model with PD was established via injection of MPTP. Normal or MPTP-induced PD like animals were treated with FMT from healthy normal mice. Pole test and traction test were performed to examine the effects of FMT on motor function of PD mice. Fecal SCFAs were assessed by gas chromatography-mass spectrometry. The α-syn level in […]

Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson’s Disease via the TLR4/PI3K/AKT/NF-κB Pathway Stimulated by α-Synuclein Read More »

Pursuing Multiple Biomarkers for Early Idiopathic Parkinson’s Disease Diagnosis

Currently, there is no objective molecular or biochemical test for PD; its diagnosis is based on clinical criteria, mainly by cardinal motor symptoms, which manifest when patients have lost about 60–80% of dopaminergic neurons. Therefore, it is urgent to establish a panel of biomarkers for the early and accurate diagnosis of PD. Once the disease

Pursuing Multiple Biomarkers for Early Idiopathic Parkinson’s Disease Diagnosis Read More »

Neuroprotective effect of Lactobacillus plantarum DP189 on MPTP-induced Parkinson’s disease model mice

The results indicated that L. plantarum DP189 improved behavioral ability and increased the levels of 5-hydroxytryptamine and dopamine of PD mice. L. plantarum DP189 significantly increased the positive rate of tyrosine hydroxylase cells. L. plantarum DP189 activated the ERK2 and AKT/mTOR pathways, promoted the expression of Bcl-2, and inhibited the activities of Bax and Caspase 3. The results indicated that L. plantarum DP189

Neuroprotective effect of Lactobacillus plantarum DP189 on MPTP-induced Parkinson’s disease model mice Read More »

Dietary patterns affect Parkinson’s disease via the microbiota-gut-brain axis

The Mediterranean diet reduces the risk of PD with favorable alternations of intestinal microbiota, increases levels of SCFAs, and reduces the TMAO level. Calorie restriction and Fasting-mimicking diet show some neuroprotective effects on PD via increasing β-HB, FGF21, and Ghrelin levels. Meanwhile, both ketogenic and protein-restricted diets show a striking effect on ameliorating motor impairment

Dietary patterns affect Parkinson’s disease via the microbiota-gut-brain axis Read More »

Short-chain fatty acids-producing probiotics: A novel source of psychobiotics

Psychobiotics—live microorganisms with potential mental health benefits, which can modulate the microbiota-gut-brain-axis via immune, humoral, neural, and metabolic pathways—are emerging as novel therapeutic options for the effective treatment of psychiatric disorders Recently, microbiome studies have identified numerous putative psychobiotic strains, of which short-chain fatty acids (SCFAs) producing bacteria have attracted special attention from neurobiologists. Recent

Short-chain fatty acids-producing probiotics: A novel source of psychobiotics Read More »

Design of synthetic human gut microbiome assembly and butyrate production

Guided by the model, we identify constraints on butyrate production by high species richness and key molecular factors driving butyrate production, including hydrogen sulfide, environmental pH, and resource competition. In sum, our model-guided approach provides a flexible and framework for understanding and accurately predicting community assembly and metabolic functions. CLICK TO REVIEW

Design of synthetic human gut microbiome assembly and butyrate production Read More »

Investigating Causal Relations Between Circulating Metabolites and Alzheimer’s Diseases: a Mendelian Randomization Study

Our findings provided robust evidence supporting causal effects of circulating glycoprotein acetyls, ApoB, LDL cholesterol, and serum total cholesterol on higher risk of AD, whereas glutamine showed the protective effect. Further research is required to decipher the biological pathways underpinning associations. CLICK TO REVIEW

Investigating Causal Relations Between Circulating Metabolites and Alzheimer’s Diseases: a Mendelian Randomization Study Read More »

Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease

Parkinson’s disease (PD) is a complicated neurodegenerative disease attributed to multifactorial changes. However, its pathological mechanism remains undetermined. Accumulating evidence has revealed the emerging functions of gut microbiota and microbial metabolites, which can affect both the enteric nervous system and the central nervous system via the microbiota-gut-brain axis. Accordingly, intestinal dysbiosis might be closely associated

Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease Read More »

Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson’s disease

Finally, the pros and cons of the current treatments for PD, including those targeting microbiota, are assessed. Advancements in research techniques, further studies on levels of specific strains and longitudinal prospective clinical trials are urgently needed for the identification of early diagnostic markers and the development of novel therapeutic approaches for PD. CLICK TO REVIEW

Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson’s disease Read More »

Air pollution, surrounding green, road proximity and Parkinson’s disease: A prospective cohort study

We found that PM2.5 were associated with increased risk of incident PD while surrounding green was associated with decreased risk of PD. Future studies about PD etiology may benefit from including multiple environmental exposures to address potential joint associations. CLICK TO REVIEW

Air pollution, surrounding green, road proximity and Parkinson’s disease: A prospective cohort study Read More »